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1. Introduction 
During the last decades advances in neonatal intensive care have led to an impressive 
decrease of neonatal mortality and morbidity. However, infectious episodes in the early 
postnatal period still remain serious and potentially life-threatening events with a mortality 
rate of up to 50% in very premature infants. [1, 2]  The signs and symptoms of neonatal 
sepsis can be clinically indistinguishable from various noninfectious conditions such as 
respiratory distress syndrome or maladaptation. Therefore rapid diagnosis is crucial for 
preventing the child from an adverse outcome. The current practice of starting empirical 
antibiotic therapy in all neonates showing infection-like symptoms results in their exposure to 
adverse drug effects, nosocomial complications, and in the emergence of resistant strains. [3] 
Sepsis results from the complex interaction between the invading microorganism and the 
host immune, inflammatory, and coagulation response. [4, 5] Inflammatory cytokines  
(TNF-α, IL-1β, IL-6, IL-8, IL-15, IL-18, MIF) and growth factors (IL-3, CSFs), and their 
secondary mediators, including nitric oxide, thromboxanes, leukotrienes, platelet-activating 
factor, prostaglandins, and complement, cause activation of the coagulation cascade, the 
complement cascade, and the production of prostaglandins, leukotrienes, proteases and 
oxidants. [6]  
Laboratory sepsis markers represent a helpful tool in the evaluation of a child with clinical 
signs and complement the evaluation of a neonate with a potential infection. During the last 
decades efforts were done to improve laboratory sepsis diagnosis and a variety of the above 
mentioned markers and more were studied with different success. Despite the promising 
results for some of them current evidence suggests that none of them can consistently 
diagnose 100% of infected cases. C-reactive protein (CRP) is the most extensively acute 
phase reactant studied so far and despite the ongoing rise (and fall) of new infection 
markers it still remains the preferred index in many neonatal intensive care units.  
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There is great interest in rapid diagnostic tests that are able to safely distinguish infected 
from uninfected newborns, especially in the early phase of the disease. [7] In fact, a delayed 
start of the antibiotic treatment may be no more able to stop the fulminant clinical course 
with development of septic shock and death within hours after the first clinical symptoms. 
[8] In the era of multi-resistant microorganisms, it is as well important to avoid the 
unnecessary use of antibiotics in sepsis-negative infants.  
2. Structure and function of CRP 
CRP was first described in 1930 by Tillet and Francis at Rockefeller University. [9] They 
observed a precipitation reaction between serum from patients suffering acute 
pneumococcal pneumonia and the extracted polysaccharide fraction C from the 
pneumococcal cell wall. This reaction could not be observed when using serum of neither 
healthy controls nor the same pneumonia patients after they had recovered. In view of the 
fact that the polysaccharide fraction was a protein the C-reactive component in the serum 
was named C-reactive protein. [9] By the 1950s CRP had been detected in more than 70 
disorders including acute bacterial, viral, and other infections, as well as non-infectious 
diseases such as acute myocardial infarction, rheumatic disorders, and malignancies. [10] 
All of these disorders of disparate etiology had in common the theme of inflammation 
and/or tissue injury. [11]  
CRP is composed by five identical subunits arranged in a cyclic pentameter shape. The 
whole protein has a diameter of 102 Å (1 Ångström = 10-10 m) and a molecular weight of 118 
000 Daltons. [12] All subunits have the same orientation; therefore the whole protein has 
two faces, a ‘recognition’ face exhibiting five phosphocholin-binding sites and an ‘effector’ 
face containing complement and Fc-receptor-binding sites. [12] The principal ligand to CRP 
with the highest binding affinity is phosphocholin, which is found in lipopolysaccharid and 
cell walls of many bacteria and micro-organisms as well as in the outer leaflet of most 
biological membranes. [12] 
After binding to a macromolecular ligand CRP is recognized by the component C1q of the 
complement system and activates it on the classical pathway. CRP-ligand complexes bind to 
the Fc-receptor on neutrophil granulocytes, macrophages, etc as well and thus promote 
phagocytosis of the pathogen. CRP further activates monocytes and macrophages and 
stimulates the production of pro-inflammatory cytokines such as Interleukin-1 and Tumor 
necrosis factor α. [12, 13] 
3. CRP is part of the acute-phase-response 
The acute-phase-response is a physiological and metabolic reaction to an acute tissue injury 
of different etiology (trauma, surgery, infection, acute inflammation, etc) which aims to 
neutralize the inflammatory agent and to promote the healing of the injured tissue. [11]  
After a trauma or the invasion of microorganisms an acute localized inflammatory reaction 
is initiated by activation of local resident cells. The contact with bacterial endo-or exotoxins 
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initiates the release of prostaglandins, leucotriens, and histamine, which results in 
vasodilatation, elevated vascular permeability, sensibilization of nozizeptors, and attraction 
and activation of further inflammatory cells.  
Activated fibroblasts, leukocytes, and endothelial cells produce pro-inflammatory cytokines 
including IL-1, TNF- α, and IL-6. They are responsible for the development of fever, 
lethargy, arthralgia, and headache, they activate the vascular endothelial cells, regulate 
proliferation of T-and B-lymphocytes, activate macrophages, have pro-coagulatory effects 
on endothelial cells, and they induce the production of acute-phase-proteins in the 
hepatocytes of the liver.  
Acute-phase-proteins form a heterogeneous group and include components of the 
complement system, coagulation factors, protease inhibitors, metal binding proteins, CRP, 
and other proteins that increase or decrease by more than 25% during an inflammatory 
reaction. [11-13]  
The production of CRP in the hepatocytes is mainly induced by IL-6 but can be further 
increased by synergy with IL-1. [14] ] Some authors have aimed to determine the normal 
serum CRP concentration in healthy adults: In 1981 Shine et al. [15] evaluated serum 
concentration of CRP determined by radioimmunoassay in 468 sera from normal adult 
volunteer blood donors and reported on a median concentration of 0.8 mg/l with a 90th 
percentile of less than 3.0 mg/l. More recently, Rifai and Ridker [16]  used three different 
high-sensitivity techniques to determine CRP distributions in their cohort consisting of 22 
thousand healthy adults from the Unites States. The median CRP values for men and 
women were 1.5 and 1.52 mg/l, the 90th percentiles were 6.05 and 6.61 mg/l, respectively. 
Similarly, Imhof et al [17] examined CRP values from 13 thousand apparently healthy men 
and women from different populations in Europe. The reported median concentration in the 
single cohorts ranged from 0.6 to 1.7 mg/l, the 90th percentiles from 3.2 to 8.0 mg/l.  
During the acute-phase-response the hepatic synthesis rate increases within hours and can 
reach levels 1000 fold. [10, 12] CRP levels remain high as long as the inflammation or tissue 
damage persists and then decrease rapidly. The half life time of CRP is 19 hours under all 
conditions, which shows the synthesis rate alone is responsible for the actual serum 
concentration. [18]  
4. Serial CRP determinations are of high sensitivity in diagnosis of 
neonatal sepsis 
CRP passes the placenta only in very low quantities, therefore, any elevation in the neonate 
always represents endogenous synthesis. [19] De novo hepatic synthesis starts very rapidly 
after a single stimulus with serum concentrations rising above 5 mg/l by about 6 hours and 
peaking around 48 hours. [20]  
In diagnosis of early onset sepsis previous studies reported on widely differing sensitivities 
and specificities of CRP ranging from 29% to 100% and from 6% to 100%, respectively. [11, 
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21, 22] These extreme variations are a result of different reference-values, test 
methodologies, patient characteristics and inclusion criteria, number of samples taken, and 
sampling time. Furthermore, definitions of sepsis widely differ between studies making 
serious comparisons hardly possible.  
The sensitivity of CRP is known to be the lowest during the early stages of infection. [23-25] 
For a single CRP determination at the time of first sepsis evaluation the sensitivity and 
specificity range from 22% to 69% and from 90% to 96%, respectively. [23, 24, 26-29] Similar 
results were reported for cord blood CRP. Even with low cut-off values being used [1 to 5 
mg/l) sensitivities and specificities ranged from 22 to 74% and from 78 to 97%, respectively. 
[30-33] Thus, a single normal value at the initial sepsis work-up is not sufficient to rule out 
an infection [11].  
On the other hand a raised CRP is not necessarily diagnostic for sepsis, as elevations may as 
well occur due to the physiologic rise after birth or non infection associated conditions (see 
below). Therefore, concerns were raised about the reliability of CRP during the early stage 
of the disease being neither able to diagnose nor to rule out an infection with certainty. [23]  
Benitz et al. [23] found that the sensitivity in the diagnosis of culture proven early onset 
sepsis increased from 35% at the initial sepsis work-up to 79% and 89% when CRP 
determination was performed on the two following days. In a large series of 689 neonates 
(187 with sepsis) Pourcyrous et al. [24] reported a higher sensitivity for CRP levels 
determined at least 12 hours after the initial evaluation compared to the first value (54% vs. 
74%). In general the sensitivity substantially increases with serial determinations 24 to 48 
hours after the onset of symptoms, and several studies reported on sensitivities and 
specificities ranging from 78% to 98% and from 81% to 97%, respectively. [11, 21, 23-27, 34]  
Some authors have suggested that serial determinations may be useful for identification of 
infants who do not have a bacterial infection as well: Two consecutive CRP values <10 mg/l 
carry a 99% negative predictive value in accurately identifying infants not infected. [6, 21, 
23, 35-37] At 48 h after onset of symptoms with at least two normal CRP values and negative 
blood cultures infection can be ruled out and antibiotics can be stopped. [38] 
Similarly, serial CRP measurements can be helpful in monitoring the response to treatment 
in infected neonates, to determine the duration of antibiotic therapy, and to recognize 
possible complications. [24, 25, 39] In a cohort of 60 neonates with early onset sepsis Ehl et 
al. [40] demonstrated that after initiation of a successful antibiotic therapy CRP values 
further increased, peaking and consecutively decreasing after 16 hours. A CRP level that 
returned again to the normal range may indicate that the duration of antibiotic treatment 
has been sufficient allowing discontinuation of antibiotics. [35]  
5. CRP values can be elevated in non-infectious conditions  
In adults, elevated CRP concentration was described in a large variety of disorders apart 
from bacterial, viral, and fungal infections including burns, surgery, rheumatic disorders, 
malignancies, and vasculitis. [20]  
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In neonates, non infection associated elevation of CRP was described in conditions of 
maternal and perinatal distress, neonatal hypoxia, and tissue damage. Several authors have 
described links of CRP to maternal fever, stressful delivery, prolonged rupture of 
membranes and/or prolonged labor, asphyxia, meconium aspiration syndrome, 
intraventricular hemorrhage, pneumothorax, and tissue injury. [19, 24, 34, 41-49] (see  
table 1) 
 
-Perinatal asphyxia/ shock [34, 41, 43, 45] 
-Maternal fever during labor [41, 42] 
-Prolonged rupture of membranes [41-45] 
-Stressful delivery or fetal distress [19, 41, 43] 
-Prolonged labor  [42, 44, 46]  
-Clinically silent meconium aspiration[42]  
-Surfactant application [48, 64] 
-Intra-ventricular hemorrhage[34, 43] 
-Pneumo-thorax.[34] 
-Tissue injury[24] 
Table 1. Non-infectious conditions associated with increased CRP values during the first days of life. 
However, the issue on non-infectious CRP elevations in the neonate is not undisputed. 
Different studies gave to some extent inconsistent results and conditions that some authors 
described being associated with CRP elevation were not found in other analyses. The 
earliest descriptions on non infectious conditions influencing CRP derive from simple 
observations that elevated values in not infected infants might be connected to coincidental 
non-infectious conditions, though no statistical confirmation is given.  
Few investigations were performed on the association of CRP with non infectious conditions 
in healthy neonates. Chiesa et al. evaluated conditions influencing what constitutes normal 
CRP values in healthy neonates. In their analysis on 148 healthy term or near term neonates 
they identified low 5-minute Apgar score and premature rupture of membranes being 
significantly associated with CRP response at birth and pregnancy induced hypertension 
with CRP response at 24 hours of life. [45] In a similarly selected cohort of 421 healthy 
neonates including 200 premature infants they confirmed an association with the time of 
ruptured membranes and added duration of active labor, prenatal steroids, and intrapartum 
antimicrobial prophylaxis as variables that had a significant effect on CRP concentrations 
when adjusted for gestational age, gender, and sampling time. [44] 
The current literature suggests that CRP may be elevated in some non-infectious 
conditions, of which some may per se clinically mimic a bacterial infection as well. Thus, 
the up to date available information lacks in robust evidence to support a claim that 
withholding antibiotics may be justified in infants with raised CRP in the above 
mentioned conditions.  
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6. CRP performance in diagnosis of neonatal sepsis and baseline CRP 
concentrations differ between term and preterm neonates 
Even though advances in neonatal intensive care have led to increasing preterm birth rates 
and survival rates, the influences of prematurity on laboratory test results are poorly 
understood and have not been assessed systematically. This is also true for CRP, which is 
one of the most extensively studied infection markers in the neonatal period. Reports on the 
influence of gestational age on kinetics of CRP in infected and uninfected infants are limited:  
Turner et al. [50] demonstrated an association of gestational age with the magnitude of 
clinically relevant CRP responses during the first seven days after birth. In case of a 
clinically relevant CRP rise >10 mg/l the proportion of a pronounced response >60 mg/l 
increased with gestational age from 8% in newborns from 24 to 27 weeks to 25% in 
newborns from 40 to 41 weeks.  
Several other authors have contributed to the growing body of evidence further supporting 
the difference in CRP response to infection between term and preterm infants. In a cohort of 
348 infants Kawamura et al. [25] reported a lower sensitivity of CRP in the diagnosis of 
neonatal sepsis in preterm compared to term newborns (61.5% vs. 75%). 
Doellner et al. [51] described a significantly lower CRP increase induced by infection in 
preterm compared to term infants. In their cohort of 42 newborns with either culture proven 
or probable sepsis infants with a gestational age less than 35 weeks had lower CRP values 
and lower CRP peak values compared to infants with a gestational age greater than 35 
weeks (CRP values 0 vs 18 mg/l, CRP peak values 15 vs 52 mg/l). 
We have recently reported on a lower CRP response to infection in preterm compared to 
term newborns with a lower sensitivity (53% vs. 86%), lower median values (9 vs. 18.5 mg/l), 
and a lower area under the receiver operating characteristics curve (0.799 vs. 0.890). [48] 
What might explain the observed differences of CRP values between term and preterm 
newborns? One fact might be the differences in pre- and postnatal care regarding more 
frequent prophylactic antibiotic treatment in preterm infants and their mothers during birth. 
Timing of blood sampling might be another critical point being possibly earlier in preterm 
newborns. CRP is thought to play an important role in innate immunity, as an early defence 
system against infections. As far as the endogenous immune response depends on 
gestational age CRP responses might be lower due to a less mature immunological system 
of the preterm newborn.  
Table 2 gives an overview on current literature on the association of CRP kinetics with 
gestational age and/or birth weight.  
For neonates, assessment of laboratory tests occurs within a complex context of prenatal 
growth and neonatal development. [52] Though the current literature reveals some minor 
disagreement on the effect of gestational age on CRP there is a body of growing evidence 
suggesting that the so far reported characteristics of CRP may not be as suitable for the use 
in preterm as in term newborns. Their baseline CRP values may be lower and their response 
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to infection less distinct. Prematurity of the organ systems and maturational changes in the 
immune system might result in a more distinct CRP response to delivery in uninfected 
newborns and to bacterial invasion in infected newborns. The few studies so far addressing 
this issue suggest that the diagnostic accuracy of CRP in preterm infants may benefit from a 
re-evaluation of the reference intervals in this age group. [25, 44, 48, 51]  
 
Author Cohort   
Diagnostic accuracy Sensitivity (%)  
Kawamura 
et al. [25] 
348 neonates 
with suspicion of 
infection 
61.5 vs. 75 (preterm vs. term neonates) 
Hofer et al. 
[48] 
532 uninfected 
and infected 
neonates 
53 vs. 86 (preterm vs. term neonates 
at 8 mg/l cut-off value) 
Highest sensitivity in preterm infants at the cut-off 5.5 mg/l 
(74%) and at 10.5 mg/l in term infants (86%) 
CRP concentration median (mg/l) peak (mg/l)  
Doellner et 
al. [51] 
42 neonates with 
probable or 
proven sepsis 
0 vs. 18 15 vs. 52 (<35 weeks vs. ≥35 weeks) 
Hofer et al. 
[48] 
499 uninfected 
neonates 
0.2 vs. 2.0 9.0 vs. 26.2 (preterm vs. term neonates) 
33 neonates with 
proven sepsis 
9.0 vs. 18.5 40.4 vs. 98.6 (preterm vs. term neonates) 
Ishibashi et 
al. [46] 
110 uninfected 
symptomatic 
neonates 
Gestational age and birth weight significantly influence 
hsCRP concentration within 48 hours after birth. Infants with 
low gestational age and low birth weight had lower hsCRP 
concentration (p=.013 and .024, respectively).  
Chiesa et al. 
[44] 
421 healthy 
neonates 
By regression analysis mean CRP increased by 6% per week 
gestational age at delivery (p<.01) and per 2.4% per 100 g 
increase in birth weight (p<.01) 
Turner et al. 
[50] 
3574 neonates In case of a clinically relevant CRP rise >10 mg/l, the 
proportion of a pronounced response >60 mg/l increased 
with gestational age from 8% in newborns from 24 to 27 
weeks to 25% in newborns from 40 to 41 weeks.  
Table 2. Overview on current literature on the difference in CRP kinetics between term and preterm 
neonates.  
7. Performance of CRP in diagnosis of neonatal sepsis can further be 
enhanced by combining it with early sensitive markers 
An important limitation of CRP is the low sensitivity during the early phases of sepsis. By 
then values are often still normal, though the consequences of the bacterial invasion are 
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already apparent and a delay of the initiation of antibiotic therapy may be associated with 
an adverse outcome. CRP takes ten to twelve hours to significantly change after the onset of 
infection. [6] Earlier in the inflammatory cascade activated macrophages release pro-
inflammatory cytokines (IL-1, IL-6, TNF-α) and growth factors (IL-3, CSFs) inducing the 
hepatic synthesis of acute-phase-reactants and the activation of neutrophils. The increase of 
cytokines therefore precedes the changes of CRP. Of the many mediators studied, much 
attention has been focused on IL6, IL8, and TNF-α.  
IL-6 increases rapidly after the bacterial invasion and was demonstrated to have a high 
sensitivity during the early stages of sepsis (80%-100%) even when determined from 
umbilical cord blood (87%-100%). [29, 53) However, a short half life caused by plasma 
protein binding, hepatic clearance, and inactivation results in a rapid normalization of serum 
levels and a decrease of sensitivity during the later course of the disease, even though the 
infection persists. IL-8 and TNF-α have very similar characteristics and kinetic properties to IL-
6. Both are pro-inflammatory cytokines predominantly produced by activated phagocytes in 
response to systemic infection and inflammation. [53] While studies report on a reliable 
diagnostic accuracy of IL-8 with a sensitivity of 69%-100%, the usefulness of TNF-α as a 
diagnostic marker has not been found to be as good as either IL-6 or IL-8. [53, 54]  
Similar to CRP procalcitonin is another important acute-phase reactant produced by 
monocytes and hepatocytes. It has the advantage of increasing more rapidly after contact to 
bacterial endotoxin with levels rising after four hours and peaking at six to eight hours [55] 
In a recent meta-analysis the sensitivity and specificity in the diagnosis of early onset sepsis 
were 76% (range 68–82%) and 76% (60–87%). [56] Though the sensitivity during the early 
stages of sepsis may be superior to CRP, the significant rapid variations of basal levels after 
birth, the increase after non-infectious conditions such as asphyxia, maternal pre-eclampsia, 
and intracranial hemorrhage,[57] and the need for several different cut-off values with 
changing neonatal age, have limited its diffusion as an early marker in comparison to CRP.  
Specific leukocyte cell surface antigens are known to be expressed in substantial quantities 
after inflammatory cells are activated by bacteria or their cellular products. [62] From the 
amount of surface markers studied neutrophil CD11b and CD64 appear most promising for 
diagnosis of neonatal sepsis. CD11b expression increases considerably within a few minutes 
after the inflammatory cells come into contact with bacteria and endotoxins. [58, 59] The 
sensitivity and specificity of CD11b for diagnosing early onset neonatal sepsis are 86–100% 
and 100% respectively. [7, 53] CD64 has a sensitivity ranging between 81% and 96% and a 
NPV between 89% and 97%. [60] Though promising, estimation of cell surface markers is 
limited by the need for sophisticated equipment and the need to process blood samples 
rapidly before neutrophils die from apoptosis or the surface antigens are down regulated. [61]  
Despite the favorable claims by many studies, many of these diagnostic markers fail to meet 
the stringent demands required for clinical practice. High costs, limited availability of 
specimens at the appropriate time, and complexity of the assay methods all limit the clinical 
applicability. More importantly, the relatively small sample size in most studies, the lack of 
clear reference values for many diagnostic markers still prohibit the use of most of these 
parameters in clinical practice.  
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Sensitivity is low during the early phase of infection. The performance of serial 
determinations 24 to 48 hours after the onset of symptoms is recommended, as it clearly 
improves diagnostic accuracy.  
CRP is particularly useful for ruling out an infection and for monitoring the response to 
treatment and guiding the duration of the antibiotic therapy. Two consecutive values <10 
mg/l determined more than 24 hours apart identify infants unlikely to be infected or in 
whom infection has resolved. 
CRP values undergo a physiological 3-day-rise after birth and non-infectious confounders 
such as meconium aspiration syndrome and perinatal maternal risk conditions may elevate 
CRP values in otherwise healthy newborns. 
Preterm neonates have lower baseline CRP values and a lower CRP response to infection in 
compared to term newborns.  
Data on non infectious CRP elevations in otherwise healthy newborns are inconsistent and 
does currently not allow drawing recommendations on the continuation or withdrawal of 
antibiotics in these infants.   
Up to date the most used cut-off value is 10 mg/l irrespective of the gestational and 
postnatal age of the neonate. Cut-off values adapted to the gestational and postnatal age 
may better reflect neonatal physiology.  
In order to compensate for the diagnostic weakness during the early phases of infection 
initial CRP determination should be combined with determination of early and sensitive 
markers. Suitable markers include but are not limited to PCT, IL6, and IL8. Many further 
parameters may provide similar good results but are not yet sufficiently examined to be 
applied to clinical practice.  
Table 3. CRP facts.  
At the moment none of the described current diagnostic markers are sensitive and specific 
enough to influence the judgment to withhold antimicrobial treatment independent of the 
clinical findings. Efforts were done to improve diagnostic accuracy by combining multiple 
markers in order to further enhance the diagnostic accuracy of these mediators in 
identifying infected cases.  
CRP has been investigated in combination with a variety of “new” infection markers 
including cytokines, surface markers, and other acute-phase-reactants with promising 
results. Especially the combination with an early sensitive marker such as PCT, IL6, IL8, 
CD11b, and CD64 increases the sensitivity to values between 90% and 100% in most studies.  
8. Do special subpopulations need special CRP reference values? 
Especially in the early neonatal period, many physiological and metabolic processes are in 
change and differ from every later moment in life. These changes affect several laboratory 
parameters as well and many reference values and serum kinetics substantially differ to 
later periods. [62]  
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Reliable reference values are crucial for obtaining an adequate diagnostic accuracy. Upper 
limits for CRP during the first days of life have mainly been established from uninfected but 
symptomatic neonates. The cut-off values reported in the literature range from 1,5mg/l to 20 
mg/l with thus wide ranging sensitivities and specificities. [11, 63] The up to date most used 
upper limit for CRP during the first days of life of 10 mg/l has been established in 1987 by 
Mathers and Pohlandt. [28] One decade later, Benitz et al. evaluated CRP levels in 1002 
episodes of suspected early onset sepsis and confirmed the value being an appropriate 
threshold level. [23] 
Use of CRP in the first few days after birth is complicated by a nonspecific rise primarily 
related to the stress of delivery. [11, 45] This rise of CRP starts shortly after birth and peaks 
with 13 mg/l in term and 11 mg/l in preterm newborns during the second and third day of 
life, respectively. [44] These observations raise concern about the static cut-off value not 
reflecting the physiologic kinetics of CRP after birth. In view of the physiologic dynamics of 
CRP during the first days after birth and the influence of gestational age on its response to 
infection, it appears reasonable to reconsider this static cut-off value and evaluate the 
possible advantages of the introduction of dynamic reference values. However, the current 
literature lacks sufficient evidence to make recommendations for the use in clinical practice.  
9. Conclusion 
CRP is one of the most widely available, most studied, and most used laboratory tests for 
neonatal bacterial infection and despite the continuing emergence of new infection markers 
it still plays a central role in the diagnosis of early onset sepsis of the neonate. CRP has the 
advantage of being well characterized in numerous studies and the extensive knowledge on 
its properties and limitations makes it safer compared to other, newer markers. Still, further 
research is needed on the topics of the influence of gestational age on CRP kinetics in 
infection, non-infectious confounders, and the evaluation of dynamic and gestational age 
dependent reference values.  
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